JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pasque, M. K.
Right arrow Articles by Wechsler, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pasque, M. K.
Right arrow Articles by Wechsler, A. S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 83, 390-398, Copyright © 1982 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Ribose-enhanced myocardial recovery following ischemia in the isolated working rat heart

MK Pasque, TL Spray, GL Pellom, P Van Trigt, RB Peyton, WD Currie and AS Wechsler

Recovery for myocardial adenosine triphosphate (ATP) following moderate periods of ischemic is dependent upon the availability of adenosine monophosphate (AMP) and diphosphate (ADP) for rephosphorylation. Recovery of AMP and ADP levels following ischemia is, in turn, determined by the rates of salvage and de novo adenine nucleotide synthesis. Phosphoribosyl pyrophosphate (PRPP) availability is rate limiting in both salvage and de novo adenine nucleotide synthesis. Parenteral ribose infusions in rats have been documented to elevate myocardial PRPP levels with resultant enhancement of adenine nucleotide synthesis. In this study postischemic recovery of myocardial function and ATP levels in isolated, working rat hearts given ribose infusions before and after ischemia was compared with recovery in control hearts subjected to the same protocol without ribose administration. The mean percent of functional recovery in control hearts following 15 minutes of warm ischemia reached values of 56.7 +/- 4.1%, 63.5% +/- 4.3%, 65.9% +/- 4.6%, and 70.5% +/- 4.7% at 2, 5, 10, and 15 minutes of work following ischemia. Hearts perfused with ribose demonstrated improved mean percent return of function at similar intervals of postischemic work with values of 67.9% +/- 4.2%, 73.7% +/- 3.7%, 81.0% +/- 3.5% (* = p less than 0.02 versus control) *and 85.4% +/- 3.3%, *respectively. Determinations of myocardial ATP levels (mumoles/gm of dry weight) made at the end of 15 minutes of postischemic work were significantly higher (p less than 0.02) in the ribose-treated hearts (18.9 +/- 0.7) than in controls (16.3 +/- 0.6). Infusion of ribose before and after ischemia is a biochemically logical method of improving postischemic myocardial ATP and functional recovery by manipulation of adenine nucleotide synthetic pathways.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Lamberts, E. Caldenhoven, M. Lansink, G. Witte, R. J. Vaessen, J. A. St Cyr, and G. J. M. Stienen
Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1869 - H1876.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. Op 't Eijnde, M. Van Leemputte, F. Brouns, G. J. Van Der Vusse, V. Labarque, M. Ramaekers, R. Van Schuylenberg, P. Verbessem, H. Wijnen, and P. Hespel
No effects of oral ribose supplementation on repeated maximal exercise and de novo ATP resynthesis
J Appl Physiol, November 1, 2001; 91(5): 2275 - 2281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. W. Goodwin, D. M. Cohen, and H. Taegtmeyer
[5-3H]glucose overestimates glycolytic flux in isolated working rat heart: role of the pentose phosphate pathway
Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E502 - E508.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. F. Pauly and C. J. Pepine
D-Ribose as a Supplement for Cardiac Energy Metabolism
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 249 - 258.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. P. Chen, H. B. Bittner, R. D. Davis, P. V. Trigt, and R. J. Folz
Physiologic Effects Of Extracellular Superoxide Dismutase Transgene Overexpression On Myocardial Function After Ischemia And Reperfusion Injury
J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 450 - 454.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
C. Muller, W. Isselhard, J. Sturz, A. Wahle, H. Witmanowski, J. V. Armas-Molina, and S. Saad
Pressure-Controlled Reperfusion Improves Postischemic Recovery of LV-Hypertrophied Rat Hearts
Angiology, June 1, 1989; 40(6): 574 - 580.
[Abstract] [PDF]


Home page
ScienceHome page
H. Zimmer, H Ibel, U Suchner, and H Schad
Ribose intervention in the cardiac pentose phosphate pathway is not species-specific
Science, February 17, 1984; 223(4637): 712 - 714.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The American Association for Thoracic Surgery.